findmyKOL
Clinical trialNCT00350714TerminatedPhase 2Interventional

BreathID Multi-center HCV Liver Breath Test Study

SponsorMeridian Bioscience, Inc.Enrollment75Hepatitis C
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel
  • Hadassah Medical Center

    Jerusalem, Israel

United States
  • Mount Sinai School of Medicine

    New York, New York, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • U.S. Dept. of Veteran Affairs, Hunter Holmes Mcguire Medical Center

    Richmond, Virginia, United States

  • Virginia Commonwealth Univeristy

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2006
Primary completion
28 Feb 2007
Completion
28 Feb 2007
Last update posted
20 Dec 2022
Registered enrollment
75
Registry id
NCT00350714

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.